Related Experiment Videos
Missense mutations in disease genes: a Bayesian approach to evaluate causality
G M Petersen1, G Parmigiani, D Thomas
1Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD 21205, USA. gpeterse@jhsph.edu
American Journal of Human Genetics
|June 19, 1998
Summary
Interpreting missense mutations in disease genes is challenging. A new Bayesian method uses family genetic data to determine if mutations like BRCA1 R841W and APC I1307K cause diseases such as cancer.
Area of Science:
- Genetics
- Bioinformatics
- Computational Biology
Background:
- Interpreting missense mutations in disease-causing genes is a significant challenge.
- Single amino acid alterations often have unclear disease-causing potential.
- Genetic analysis of familial data is crucial for understanding mutation impact.
Purpose of the Study:
- To develop a Bayesian approach for evaluating missense mutations.
- To assess the disease-causation probability of mutations using familial genetic information.
- To apply the method to common cancer-related genes.
Main Methods:
- A Bayesian statistical framework utilizing genetic data from affected relatives.
- Family ascertainment through known missense-mutation carriers.
- Calculation of posterior probability based on relative relationships, mutation frequency, and phenocopy rates.
Main Results:
- The Bayesian approach successfully evaluated missense mutations in BRCA1 (R841W) and APC (I1307K).
- High posterior probabilities (.836 and .985) indicated these mutations are likely disease-causing.
- Bayes factors supported causality with values of 5.09 and 66.97.
Conclusions:
- The proposed Bayesian method effectively determines the disease-causing potential of missense mutations.
- This approach aids in evaluating genetic variants for common diseases like breast and colorectal cancer.
- The study also addressed scenarios with rare alleles, unknown penetrance, and allele frequencies.